Monash University is positioned to deliver high quality research and innovation that has an impact in communities that need it most.
We are uniquely poised to capitalise on sound investment by the government across healthcare, engineering and basic research domains to accelerate the growth of the neurotechnology industry.
There is growing recognition that we must position the medical technology industry more broadly as a cornerstone of our country’s future wellbeing and economy. Investment in the Australian medical technology ecosystem will support the continued repositioning of Australia’s economy towards high value products with a strong focus on local manufacturing. Investment in this project will improve lives and create highly skilled jobs, both key metrics for a healthy country.
Throughout Stage 1 of the project, the Cortical Frontiers team developed new partnerships with world-leading experts in spinal cord injury rehabilitation, including:
- Victorian Spinal Cord Service based at The Austin Hospital
- The Australian Quadriplegic Association
- The Rehabilitation and Neural Engineering Laboratory at University of Pittsburgh, USA
- Sydney Bionics Translation Centre in the School of Biomedical Engineering at The University of Sydney
Building on our existing strong relationship with The Alfred Hospital in Melbourne, these new partnerships will provide Stage 2 of the project with the clinical, engineering and consumer-focused inputs required to develop and clinically trial transformative new technologies improving the care of blindness, spinal cord injury and other neurological conditions.
Monash Technology Precinct
This project will have access to critical research infrastructure provided by the Monash Technology Precinct, including the Melbourne Centre For Nanofabrication, Monash Biomedical Imaging, Biomedical Materials Translational Facility (BMTF) and Monash Centre for Additive Manufacturing (MCAM).
Monash Technology Precinct is at the centre of the Monash Innovation Cluster, Victoria’s largest employment hub outside the Melbourne CBD. The Monash Technology Precinct brings together advanced manufacturing, future technologies, health and education and contributes $9.4 billion to the Victorian economy each year, employs more than 82,000 people, and supports more than 13,000 businesses. Seventy per cent of high-value and advanced manufacturing in the state operates here.
The Precinct enables state-of-the-art research and development by driving the collaboration of our centres, platforms and facilities with key government and industry players. Major facilities and partnerships include the Australian Synchrotron, CSIRO, Monash Biomedicine Discovery Institute, New Horizons, Woodside Innovation Centre and the Victorian Heart Hospital.